A carregar...
A gene expression signature of CD34(+) cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib
In chronic-phase chronic myeloid leukemia (CML) patients, the lack of a major cytogenetic response (< 36% Ph(+) metaphases) to imatinib within 12 months indicates failure and mandates a change of therapy. To identify biomarkers predictive of imatinib failure, we performed gene expression array pr...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society of Hematology
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2808155/ https://ncbi.nlm.nih.gov/pubmed/19837975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-210732 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|